Represented a regional dialysis provider in a $5 million joint-venture transaction with a national dialysis company. Advised the client on all stages of the deal, including structuring, regulatory review, negotiation of joint-venture and operating documents, and closing coordination. The engagement involved complex healthcare regulatory considerations, including joint-venture compliance, state facility-licensure strategy, and alignment with federal fraud and abuse frameworks.